Evidence map›Paper›PMID 38865272›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Alternative oxidase blunts pseudohypoxia and photoreceptor degeneration due to RPE mitochondrial dysfunction.

Ming Chen, Yekai Wang, Roopa Dalal, Jianhai Du, Douglas Vollrath

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. RPE-specific MCT2 expression promotes cone survival in models of retinitis pigmentosa.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ming ChenDepartment of Genetics, Stanford University School of Medicine, Palo Alto, CA 94305.ORCID 0000-0003-3953-2904
Yekai WangDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV 26506.
Roopa DalalDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA 94305.
Jianhai DuDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV 26506.ORCID 0000-0002-2019-8128
Douglas VollrathDepartment of Genetics, Stanford University School of Medicine, Palo Alto, CA 94305.

Funding

Metabolic dysfunction from ECM remodeling in diseases of human RPER01EY034364 · NEI · UNIVERSITY OF WASHINGTON · PI Jennifer Rayming Chao, Jianhai Du · 2022 to 2026
$2.8M
Regulators of retinal metabolism in healthy and degenerating retinasR01EY031720 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ASH, JOHN D, DU, JIANHAI · 2020 to 2024
$2.4M
RPE Energy Metabolism and Cell PhenotypeR01EY025790 · NEI · STANFORD UNIVERSITY · PI VOLLRATH, DOUGLAS E. · 2016 to 2021
$2.4M
FGF21 as a mediator of RPE mitochondrial dysfunctionR01EY034002 · NEI · STANFORD UNIVERSITY · PI Douglas E. Vollrath · 2023 to 2026
$2.1M
Retinal Mitochondrial Metabolism in Alzheimer's DiseaseR01EY031324 · NEI · WEST VIRGINIA UNIVERSITY · PI DU, JIANHAI · 2021 to 2024
$2.0M
Proline metabolism in retinal healthR01EY032462 · NEI · WEST VIRGINIA UNIVERSITY · PI DU, JIANHAI · 2021 to 2025
$1.9M
HHS | National Institutes of Health (NIH) EY025790HHS | National Institutes of Health (NIH) EY031324HHS | National Institutes of Health (NIH) EY032462HHS | National Institutes of Health (NIH) EY034002NEI NIH HHS R01 EY025790NEI NIH HHS R01 EY031324NEI NIH HHS R01 EY031720NEI NIH HHS R01 EY032462NEI NIH HHS R01 EY034002NEI NIH HHS R01 EY034364
6 · The paper itself

Abstract

Loss of mitochondrial electron transport complex (ETC) function in the retinal pigment epithelium (RPE) in vivo results in RPE dedifferentiation and progressive photoreceptor degeneration, and has been implicated in the pathogenesis of age-related macular degeneration. Xenogenic expression of alternative oxidases in mammalian cells and tissues mitigates phenotypes arising from some mitochondrial electron transport defects, but can exacerbate others. We expressed an alternative oxidase from

Indexed as

MitochondriaOxidoreductasesPlant ProteinsRetinal Pigment EpitheliumAlternative OxidaseAnimalsCiona intestinalisMiceMitochondrial ProteinsPhotoreceptor Cells, VertebrateRetinal DegenerationUbiquinoneAlternative OxidaseMitochondrial ProteinsOxidoreductasesPlant ProteinsUbiquinonealternative oxidasecoenzyme Qmitochondrial dysfunctionretinal pigment epitheliumsuccinate

Identifiers

PMID38865272
PMCPMC11194566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.